Genes, Proteins, and Metabolites in Drug-resistant Epilepsy (DRE) Patients

Not yet recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

November 15, 2024

Primary Completion Date

December 15, 2025

Study Completion Date

December 31, 2026

Conditions

Drug Resistant EpilepsyTraumatic Brain Injury Without Open Intracranial Wound

Interventions

OTHER

Routine clinical treatment

Routine clinical treatment is based on the latest international guidelines for DRE.

Trial Locations (1)

Xuanwu Hospital, Capital Medical University, Beijing

All Listed Sponsors

lead

Xuanwu Hospital, Beijing

OTHER

NCT06665880 - Genes, Proteins, and Metabolites in Drug-resistant Epilepsy (DRE) Patients | Biotech Hunter | Biotech Hunter